Abstract: A pharmaceutical composition, intended for menopausal replacement therapy, comprising a suspension of progesterone in a lipophilic medium solution of a 17-estradiol salt in the lipophilic medium, the weight ratio of progesterone to the base 17-estradiol being 25 to 600.
Type:
Grant
Filed:
August 3, 1998
Date of Patent:
December 26, 2000
Assignee:
Effik SCA BAT
Inventors:
Etienne Grasset, Didier Terracol, Javier Gil Galdona